Poor Reckitt Benckiser. Looks like they have a fight on their hands.
British drugmaker GlaxoSmithKline Plc and Colgate-Palmolive Co. are among companies expected to submit offers for Pfizer’s array of OTC consumer products in first-round bidding on Wednesday, the Wall Street Journal said.
New York-based Pfizer, the world’s largest drugmaker, is hoping to fetch about $14 billion for the products, the report said, citing people familiar with the situation.
No comments:
Post a Comment